Free Trial

Entero Therapeutics (ENTO) SEC Filings & 10K Form

Entero Therapeutics logo
$0.47 +0.02 (+4.92%)
Closing price 07/17/2025 04:00 PM Eastern
Extended Trading
$0.46 -0.01 (-2.79%)
As of 04:12 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Entero Therapeutics SEC Filings

DateFilerForm TypeView
07/16/2025
3:53 PM
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/08/2025
3:16 PM
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/02/2025
4:16 PM
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form S-1/A
06/23/2025
3:06 PM
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form S-1/A
06/10/2025
8:30 PM
Ali Arif Nasir (Filed by)
Entero Therapeutics, Inc. (Subject)
Entero Therapeutics, Inc. (Subject)
Entero Therapeutics (Subject)
Form SCHEDULE 13D/A
06/09/2025
8:55 PM
Ali Arif Nasir (Filed by)
Entero Therapeutics, Inc. (Subject)
Entero Therapeutics, Inc. (Subject)
Entero Therapeutics (Subject)
Form SCHEDULE 13D
06/05/2025
4:23 PM
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form S-1/A
06/04/2025
3:05 PM
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form DEF 14A
05/30/2025
4:25 PM
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form PRER14A
05/27/2025
5:09 AM
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form PRER14A
05/16/2025
4:04 PM
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form PRE 14A
05/15/2025
12:20 PM
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/14/2025
3:15 PM
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/09/2025
4:21 PM
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 10-K/A
04/01/2025
10:06 AM
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form NT 10-K
02/13/2025
3:59 PM
Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics (Issuer)
Paolone Richard (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/13/2025
4:00 PM
Corbett Eric (Reporting)
Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/13/2025
4:02 PM
Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics (Issuer)
Uppal Manpreet (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/06/2025
3:31 PM
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2025
3:18 PM
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2025
3:23 PM
Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics (Issuer)
Romano Sarah (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2024
6:15 AM
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/13/2024
6:00 AM
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/21/2024
6:31 AM
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/10/2024
4:00 PM
Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics (Issuer)
Romano Sarah (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
4:10 PM
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/10/2024
6:00 AM
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/29/2024
3:05 PM
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/23/2024
4:00 PM
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/22/2024
4:28 PM
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/15/2024
7:00 AM
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/15/2024
7:05 AM
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form NT 10-Q
08/14/2024
8:46 PM
Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics (Issuer)
Ramdeen Timothy R. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/07/2024
4:20 PM
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/31/2024
9:54 AM
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/26/2024
3:16 PM
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
07/23/2024
3:05 PM
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ENTO) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners